Trial Profile
A randomized controlled trial comparing botulinum toxin type A xeomin and dysport for treatment of primaryaxillary hyperhidrosis
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 23 Oct 2013
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Hyperhidrosis
- Focus Therapeutic Use
- 23 Oct 2013 New trial record
- 26 Sep 2013 Preliminary results presented at the 21st World Congress of Neurology.